Latest Amides Stories
- Farydak, an HDAC inhibitor with epigenetic activity, approved in combination for patients who received at least two prior regimens including bortezomib and IMiD1 EAST HANOVER, N.J., Feb.
Transparency Market Research added new report "Polyacrylamide Market (Non-ionic, Cationic, Anionic, and Others) for Water Treatment, Petroleum, Paper Making and Other Applications - Global
WOODCLIFF LAKE, N.J., Feb.
ReportsnReports.com adds “Global and Chinese Tolvaptan Industry, 2009-2019 Market Research Report” to its store. Dallas, TX (PRWEB) February 04, 2015
Xarelto Drug Safety Label Warns Bleeding Is A Common Adverse Reaction Of The Blood Thinner And Xarelto Bleeding Side-Effects Lawsuits Claim The Anticoagulant Does Not Have An Antidote Should Severe
Initiation of Registrational Studies Planned for This Year MORRISTOWN, N.J., Jan.
Reaction Times Outshine Those Where No Hydration Was Given* New York, NY (PRWEB) January 15, 2015 Taking Kyowa Hakko USA's Sustamine® L-Alanyl-L-Glutamine
MUMBAI and BALTIMORE, January 6, 2015 /PRNewswire/ -- Pharma Major Lupin Limited announced today that its US subsidiary, Lupin Pharmaceuticals Inc.
ReportsnReports.com adds “Seborrhea - Pipeline Review, H2 2014” to its store.
- A political dynamiter.